Are you an experienced leader, with good commercial acumen and experienced in the downstream processing and CMC of viral vectors?
As part of our growth, Albumedix has a unique and exciting opportunity where you will head up and manage our new viral vector / vaccine application research group.
Albumedix is an established and expanding biotechnology company focused on enabling better therapies for patients worldwide utilising our superior recombinant human albumin products and technologies. Your role will be key to help shape and support the realisation of Albumedix’ business objectives in enabling advanced therapies.
As leader of the Viral Vector Application group you’ll be responsible for driving team performance and provide expertise in the production, particularly downstream processing of viral vectors / vaccines both within the Technology Group but also within the whole organisation. You’ll initially line manage 3 team members with the expectation of growth within the team. To begin with, as the group is developing and growing, the role will involve hands on laboratory experimentation for the realisation of the viral vector application projects.
You will be working closely with the Technology Group teams in addition to the Market Development, Business Development and Project Portfolio Management teams to develop tailored solutions to meet customers’ challenges and satisfy market needs.
This is an exciting time to join the company and where there will be opportunities to progress your career and play a critical part in our ambitious plans as we continue to expand as a company and within the Technology Group while helping more patients worldwide. The role will be based in our new Technology Centre laboratories located on the Albumedix campus in Nottingham.
- You will be a BSc graduate or PhD in biochemical engineering, biochemistry, or other life science subject with 8+ years industrial experience from development and production of final viral therapies with hands-on experience in the downstream bioprocess and CMC unit operations.
- A commercial aptitude, preferably with a contract service background of viral-based therapeutics, as well as a practical understanding of the CMC challenges faced with such modalities.
- Demonstrate strong team leadership, developing a team and managing performance.
In return we offer a range of benefits including an attractive and competitive salary, 25 days annual leave, plus statutory bank holidays, bonus, pension and private healthcare schemes.
We have a strong culture, that is supportive, collaborative and friendly and we support and encourage our employees to learn, grow and develop their skills and knowledge.
Albumedix is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our recombinant human albumin products.
We believe in empowering excellence to enable advanced therapies and unstable drug candidates reach patients worldwide. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical companies worldwide.
Headquartered in Nottingham, England with more than 100 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago.
How to apply
N2 Resourcing are recruiting for this position on behalf of Albumedix. You can be confident we process your application and enquiries in a safe and strictly confidential manner.
If you’re interested and wish to discuss this role, please call Simeon Ractliffe in confidence on 0115 698 0303 or email: email@example.com
To apply, please send us your CV and covering letter via the application link below. We aim to respond to you within 2 working days.
Related skills: Analytical Chemistry, Biochemistry, Biology, Cell & Molecular Biology, Life Science, Laboratory
You must be eligible to work in the UK. Learn more
- Employer: Albumedix
- Contact: Simeon Ractliffe
- Phone: 0115 698 0303
- Updated: 26th July 2021
- Expires: 20th August 2021